PathGroup Mobile

PathGroup’s iPhone/iPad application makes it possible for healthcare providers to review pathology, cytology, clinical and esoteric laboratory reports anywhere, any time. PathGroup Mobile provides access to patient results as soon as they are released, as well as providing historical trending capabilities.

Click here to download the PathGroup Mobile application.

Downloading PathGroup Mobile:

  1. From the home screen of your iOS device, tap on the App Store icon.
  2. In the Search box, type in PathGroup Mobile.
  3. Tap on the PathGroup Mobile app icon.  From the next screen, you can view information about the app and see screenshots.
  4. Tap on the Free button.  The button will change color and say Install App.  Tap on the Install App button and enter your iTunes account password.

How to Use PathGroup Mobile  for iPad and iPhone:

Log In

  • Enter your username and password, then tap Log In to continue.  You can log in to PathGroup Mobile using your existing PathConnect username and password.

Search for Reports

  • If you log in as a physician, the system will automatically display reports for procedures and orders placed in the last four days.  You can click the magnifying glass icon to set other search options.
  • If you log in as office staff, the system will display the search screen, where you can set your active location. You can limit your search to a specific physician, a certain date range, a particular patient, or abnormal reports only.

View Reports

  • After setting your search options and tapping the Done button, PathGroup Mobile will retrieve a list of reports.  The list can be sorted by name or procedure date.
  • Tap on a report in the list to load and view it.  You can scroll through multiple pages by swiping up and down.  You can zoom the report using the pinch gesture.
  • When your iPad is in portrait mode, the report list will be hidden when you view the report.  You can click the Report List button to see the list again. When your iPad is in landscape mode, the report list will be locked to the left side of the screen.

Directory of Services

  • Access the PathGroup Directory of Services through PathGroup Mobile by tapping on the Directory of Services tab at the bottom of the screen.

Changing Your Password

  • You can change your password on the User Info screen.

GTCR Announces Recapitalization of PathGroup

CHICAGO and NASHVILLE, Tenn. – May 13, 2022 – GTCR, a leading private equity firm, announced today that it has made a majority investment in PathGroup Holdings LLC (“PathGroup” or the “Company”) in partnership with founder and CEO Ben Davis, MD and the PathGroup management team, who have made a substantial reinvestment in the Company. As part of GTCR’s Leaders Strategy™, Dave King, the former Chairman and CEO of Labcorp, will join the PathGroup Board as Chairman, partnering with Dr. Davis and GTCR to further invest in PathGroup’s capabilities across the pathology, molecular, and genetic diagnostics modalities. Pritzker Private Capital and Vesey Street Capital Partners will also be retaining a minority ownership stake in the Company alongside GTCR and the PathGroup management team.

Click here to read the full press release.

Richard B. Hessler, MD

Medical School: University Of Vermont College Of Medicine
Residency: University Of Virginia
Board Certification: Anatomic Pathology, Neuropathology
Fellowship Training: Neuropathology – University of Virginia
Specialty: Urologic Pathology, Breast Pathology, Neuropathology
Location: Erlanger, Chattanooga, TN
Phone: 423-778-7255
Email: rhessler@pathgroup.com

Dr. Hessler joined PathGroup in 2006 and provides executive leadership in our Chattanooga, Tenn., lab serving as Medical Director.  He currently serves as Chief of Pathology at Erlanger Health System and participates in several hospital committees. Dr. Hessler is Board Certified in Anatomic Pathology and Neuropathology with fellowship training from the University of Virginia and Thomas Jefferson University, where he also completed his residency.  Dr. Hessler earned his medical degree from the University of Vermont and his bachelor’s degree in biology from the University of Pennsylvania.  An active member of the American Association of Neuropathologists and Fellow member of the College of American Pathologists, Dr. Hessler has presented at numerous clinical conferences and has contributed to multiple publications and peer reviewed journals.

2010 Archive

ANA 5 Reflex Test Code Update

ANA 9 Reflex Test Code Update

Clinical Utility of Beta hCG Test Update

Testing Provided on Site for CA 27.29 Antigen

New Regulatory Requirement for CAP 2ID

Methodology Change for Anti-CCP BioPlex

Testing Change for Celiac Disease Evaluation

Clinical Report Format Revision

Reference Range Change for CRP Highly Sensitive

DASSM Test Update

Discontinued: Test Code DASSM

DTex Technical Update

Elevated Serum Total Protein Test Update

Resulting EMR Accounts Update – Glucose LOINC

Resulting EMR Accounts Update – Lipid

Testing Provided on Site for Fecal Immunochemical Testing

Testing Provided on Site for Gliadin, IgA & IgG

Discontinued: Test Code HBSAQ

Testing Provided on Site for Inhibin B

Alert Value Test Update

Discontinuation Notice: PACE 2 Assay for Chlamydia trachomatis and Neisseria gonorrhea

Discontinued: Syphilis Screen IgG w/Reflex to FTA

Testing Provided on Site for Thyroglobulin

Testing Provided on Site for Tissue Transglutaminase IgA

Testing Provided on Site for Urinalysis with Reflex to Culture

Methodology Change for Vitamin D 25- Hydroxy Testing

Celiac Disease Evaluation Interpretive Guide

 

Hematology Oncology

pathgroup-HematologyOncology

Morphologic review and interpretation of biopsy material continues to be the backbone of oncology diagnostics, and is the basis on which PathGroup deploys complement technologies to give the clearest, most accurate picture of a patient’s malignancy from original diagnosis to the presence of minimal residual disease.

Every case is managed by a board-certified hematopathologist that works in concert with the ordering physician to understand the patient’s clinical history. That information is then integrated with the results of any testing to provide diagnostic, prognostic and therapeutic guidance for the best patient management and outcome.

As part of this approach PathGroup offers the iPath® Comprehensive Assessment for blood and bone marrow disorders. With one simple order, iPath includes a clinical pathology evaluation, bone marrow and/or blood morphology, flow cytometry, cytogenetics and/or FISH, and PCR as medically necessary to establish a diagnosis or follow disease progression. All findings are then presented in a concise summary report correlating the technologies for easy review.

Our oncology testing menu is built on a core offering that begins with morphologic examination and includes:

  • Immunohistohemistry (IHC)
  • Flow Cytometry
  • Fluorescent In Situ Hybridization (FISH)
  • Cytogenetics
  • PCR /Molecular Diagnostics

Additionally, PathGroup can provide seamless billing that allows patients to contact us directly and physicians to focus on treatment.

  • All insurances accepted; PathGroup maintains preferred provider status with an extensive national, regional and local contracted payer list
  • No patient balance billing with the exception of deductibles, co-pays and co-insurance as required by law
  • >98% of claims processed as in-network annually; rare out-of-network claims honored as in-network
Pranil Chandra, DO
Chief Medical Officer and Vice President, Genomic and Clinical Pathology Services
James L. Prescott, PhD, HCLD (ABB)
AVP of Molecular Diagnostic (MDx) Services
Vladimir Kravtsov, MD
Hematopathologist, FISH/Flow Cytometry Laboratory Medical Director

Chris Coldren, PhD

Director of Bioinformatics

Theresa Brown, PhD, FACMG

Director of Cytogenetics, FISH, and Microarray Services

Kristina Fasig, MD

Senior Hematopathologist

Heather Rietz, MD

Senior Hematopathologist
Taylor L. Hartley, MD
Hematopathologist
S. Michelle Shiller, DO, AP/CP, MGP
Molecular Genetic Pathologist

Benjamin Saylor, MD

Hematopathology, Molecular Genetic Pathologist

Services and Capabilities

PathGroup is committed to providing state-of-the-art testing in more than 80,000 square feet of lab space, featuring innovative molecular, anatomic and validation labs to support Phase I−IV clinical trials. Our objective is to become an extension of your study team, collaborating on solutions to reach a common goal: optimized study outcomes.

Leadership and direction are provided by a dedicated BioPharma Services staff to oversee your project from start to finish. Our Quality Management team drives regulatory and risk management efforts for all stakeholders. PathGroup’s Data Management group utilizes the latest in proprietary and industry standard technology to provide custom databases and essential data reporting formats.

  • Diversified molecular pathology portfolio with actionable genomic variance data
  • NGS testing from single analyte, custom panel development including translocations
  • Proprietary extraction method for enhanced DNA/RNA isolation
  • Sophisticated bioinformatics suite with integrated solutions including data analysis and customized reporting capabilities

Areas of expertise within PathGroup’s full-service laboratory include:

  • Women’s Health
  • Dermatology
  • Hematology Oncology
  • Gastroenterology
  • Molecular Oncology
  • Urology
  • Infectious Diseases
  • Non-Gyn Cytopathology
  • Inherited Genetics
  • Soft Tissue and Bone Pathology
  • Pharmacogenomics
  • Breast Pathology
  • Validation and Development

PathGroup core technologies include:

  • Immunohistochemistry (IHC)
  • Flow Cytometry
  • Cytogenetics
  • Fluorescence in Situ Hybridization (FISH)
  • Chromogenic in Situ Hybridization (CISH)
  • Polymerase Chain Reaction (PCR)
  • DNA Sequencing: single analyte to comprehensive industry leading panels
  • Array-Based Comparative Genomic Hybridization (CGA)
  • High-Sensitivity and Specialty Assays

In keeping with PathGroup’s commitment to excellence in pathology, we are CAP accredited and CLIA certified.

Contact us to schedule time to discuss your project:

biopharma@pathgroup.com
615-221-4455

Mike Huguelet

Mike Huguelet joined PathGroup in 2024 as our EVP and Chief Commercial Officer and is responsible for PathGroup’s commercial strategies. Mike has more than 20 years of healthcare leadership experience partnering with physicians and health systems across various medical specialties and leading high-performing growth teams. His previous executive roles include positions most recently with Mindpath Health, where he served as Chief Development Officer and Chief Operating Officer, U.S. Renal Care, DaVita Kidney Care, and as an Advisor for a vascular surgery practice. After beginning his career with Arthur Andersen, he has been responsible for various growth initiatives including M&A, business development/ sales, and joint venture partnerships. Mike completed an MBA with a focus in Finance at the University of Colorado at Boulder, and undergraduate degrees in Finance and MIS at Saint Louis University.

Molecular

PathGroup is an industry leader in the rapidly evolving quest to identify and understand disease at the genetic level. We are focused on delivering the most precise, expert diagnostic information to our physician partners, creating opportunities for personalized medicine and targeted therapies that lead to the best possible patient outcomes.

As the molecular pathology field continues to grow and advance in all directions, new techniques and tests are announced every day. PathGroup is not only selective about our testing menu, but careful to utilize only proven, clinically relevant, advanced technology, so our physician partners and their patients always receive results they can act on with confidence.

Our full service laboratory provides examination and interpretation of specimens for diagnostic, prognostic, predictive and residual disease testing within the following areas:

PathGroup’s core technologies include:

  • Immunohistochemistry (IHC)
  • Flow Cytometry
  • Cytogenetics
  • Fluorescence In-situ Hybridization (FISH)
  • Chromogenic In-situ Hybridization (CISH)
  • Polymerase chain reaction (PCR)
  • DNA Sequencing
  • Array-based Comparative Genomic Hybridization
  • High sensitivity and specialty assays

iPath® Comprehensive Assessment

Additionally, PathGroup offers the iPath® Comprehensive Assessment.  iPath includes clinical pathology evaluation, bone marrow and/or blood morphology, flow cytometry, cytogentics and/or FISH, and PCR as medically necessary.  A consultative review and correlation with all prior findings is performed by a PathGroup Hematopatholgist.  iPath provides a concise summary report correlation of all technologies for easy review.

The PathGroup Advantage

Our molecular pathology division provides fast, accurate results to health professionals making vital treatment decisions. Our physician-centric, patient focused approach includes:

  • Dedicated team of experienced molecular pathologists; access to a broad group of pathologists representing every subspecialty
  • Full-service laboratory, operating 24 hours a day, 365 days per year; extensive courier network
  • Rapidly evolving test menu, following the most current NCCN, CAP and ASCO guidelines and recommendations
  • Existing contracts with a broad base of insurance payors
  • Industry-leading turnaround times
  • Centralized testing facility with over 30 dedicated full-time staff in Nashville, Tenn.
  • Innovative technology solutions for patients and physicians, including iPhone, iPad and web-based applications
  • Quick-response, expert consultation from experienced pathologists
  • Medical director services available to hospitals and other laboratories
  • Full range of additional clinical and anatomic laboratory services for comprehensive service from a single source
  • Patient-friendly billing policies
  • Full Suite of Business Solutions, including client assisted billing, TC/PC, and Lab Management

 

In keeping with our commitment to excellence in pathology and laboratory medicine, we maintain certifications in multiple states, the College of American Pathologists (CAP) as well as the Clinical Laboratory Improvement Amendments (CLIA). Our physician group provides volunteer surveyors for the Laboratory Accreditation Program of the College of American Pathologists, in the of spirit of a peer based, educational approach to inspections.

Gastroenterology

PathGroup offers a testing menu built on the latest and most accurate in GI diagnostics, backed by a dedicated Gastrointestinal Pathology team to interpret and deliver accurate, timely results for the best possible patient care. With diagnostic services covering a broad spectrum of gastroenterological disorders, we share in our clients’ focus on high quality patient service.

Key Services

  • Traditional H&E Diagnostics
  • KRAS and BRAF gene testing
  • Microsatellite Instability / Lynch Syndrome Testing
  • HER-2neu Flourescent In-Situ Hybridization
  • Flow Cytometry
  • Immunohistochemistry
  • Cytochemical Histologic Stains

Why PathGroup?

Our physician-centric, patient focused approach has made PathGroup an industry leader and trusted partner for quality patient care.

  • World class GI pathology diagnostics
  • Dedicated, fellowship-trained GI pathology team
  • Direct physician communication for all primary/new malignant diagnosis.
  • Comprehensive GI pathology testing menu
  • Industry leading turnaround times and responsive customer service
  • Clear, concise reporting including color images and mapping, with photomicrographs included in abnormal or unusual cases
  • Robust Quality Assurance Program, with 5% of cases reviewed retrospectively by a second pathologist
  • Every case signed out by a fellowship trained Pathologist
  • On-site subspecialty pathology teams providing consultation when necessary at no additional charge
  • Industry leading turnaround times and responsive customer service
  • Innovative technology solutions, including iPad, iPhone and web-based applications
  • Full range of additional clinical and molecular laboratory services for comprehensive service from a single source

 

 

Contact

Corporate Headquarters
5301 Virginia Way
Brentwood, TN 37027
Toll Free: (800)-366-5847
contact@pathgroup.com

Client Services
Local Phone: 615-562-9300
Toll Free Phone: 888-474-5227
csissues@pathgroup.com

Oncology Customer Support
Phone: 855-854-6473
oncologysupport@pathgroup.com

Patient Billing Customer Service
Toll Free Phone: 855-627-4002
myaccount@pathgroup.com

Client Billing Customer Service
Toll Free Phone: 866-728-4435

Technical Support
IT Hotline: 615-221-4511
help@pathgroup.com

Human Resources
hr@pathgroup.com

Physician Recruitment
physicianapplicant@pathgroup.com

Sales and Marketing
marketing@pathgroup.com

BioPharma Services
BioPharma@pathgroup.com